Methotrexate reduces inflammatory cell numbers, expression of monokines and of adhesion molecules in synovial tissue of patients with rheumatoid arthritis

British Journal of Rheumatology

Volumn 37, Issue 5, 1998, Pages 502-508

  Dolhain, R J E M ^a   Tak, P P ^a   Dijkmans, B A C ^a   De Kuiper, P ^a   Breedveld, F C ^a   Miltenburg, A M M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adhesion molecules; Immunohistochemistry; Interleukins; Leucocytes; Methotrexate; Rheumatoid arthritis

Indexed keywords

CD3 ANTIGEN; CD38 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FOLIC ACID ANTAGONIST; INTERLEUKIN 1BETA; KI 67 ANTIGEN; METHOTREXATE; MONOKINE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOPSY; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0031874951     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/37.5.502     Document Type: Article

References (34)

1. Felson DT, Anderson JJ, Meenan RF. Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A meta-analysis of published clinical trials. Arthritis Rheum 1992;35:1117-25.
2. Cronstein BN. Molecular therapeutics. Methotrexate and its mechanism of action. Arthritis Rheum 1996; 39:1951-60.
3. Segal R, Yaron M, Tartakovsky B. Methotrexate: Mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum 1990;20:190-9.
4. Firestein GS, Paine MM, Boyle DL. Mechanisms of methotrexate action in rheumatoid arthritis. Selective decrease in synovial collagenase gene expression. Arthritis Rheum 1994;37:193-200.
5. Chang DM, Baptiste P, Schur PH. The effect of anti-rheumatic drugs on interleukin 1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol 1990;17:1148-57.
6. Hu SK, Mitcho YL, Oronsky AL, Kerwar SS. Studies on the effect of methotrexate on macrophage function. J Rheumatol 1988;15:206-9.
7. Thomas R, Carroll GJ. Reduction of leukocyte and interleukin-1β concentrations in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1993;36:1244-52.
8. Segal R, Mozes E, Yaron M, Tartakovsky B. The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum 1989;32:370-7.
9. Barrera P, Boerbooms AMTH, Demacker PMN, van de Putte LBA, Gallati H, van der Meer JWM. Circulating concentrations and production of cytokine and soluble receptors in rheumatoid arthritis patients: effects of a single dose of methotrexate. Br J Rheumatol 1994;33: 1017-24.
10. Barrera P, Boerbooms AMTh, Janssen EM, Sauerwein RW, Gallati H, Mulder J et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors. Tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 1993;36: 1070-9.
11. Chang DM, Weinblatt ME, Schur PH. The effects of methotrexate on interleukin 1 in patients with rheumatoid arthritis. J Rheumatol 1992;19:1678-82.
12. Chabner BA, Allegra CJ, Curt GA et al. Polyglutamation of methotrexate. Is methotrexate a prodrug? J Clin Invest 1985;76:907-12.
13. Balso A, Gamallo C, Martin-Mola E, Gijon-Banos J. Histologic changes in rheumatoid synovitis induced by naproxen and methotrexate. J Rheumatol 1993;20: 1472-77.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Parker RH, Pearson CM. A simplified synovial biopsy needle. Arthritis Rheum 1963;6:172-6.
16. Ritchie DM, Boyle JA, McInnes JM et al. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 1968;147:393-406.
17. van der Heijde DMFM, van 't Hof MA, van Riel PLCM et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
18. Stevens CR, Mapp PI, Revell PA. A monoclonal antibody (Mab67) marks type B synoviocytes. Rheumatol Int 1990;10:103-6.
19. Dolhain RJEM, Ter Haar NT, Hoefakker S et al. Increased expression of interferon (IFN)-gamma together with IFN-gamma receptor in the rheumatoid synovial membrane compared with synovium of patients with osteoarthritis. Br J Rheumatol 1996;35:24-32.
20. Hoefakker S, Boersma WJA, Claassen E. Detection of human cytokines in situ using antibody and probe based methods. J Immunol Methods 1995;185:149-75.
21. Tak PP, Kummer JA, Hack CE et al. Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 1994;37:1735-43.
22. Tak PP, Taylor PC, Breedveld FC et al. Reduction in cellularity and expression of adhesion molecules in rheumatoid synovial tissue after anti-TNFα monoclonal antibody treatment. Arthritis Rheum 1996;39:1077-81.
23. Tak PP, van der Lubbe PA, Cauli A et al. Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis. Arthritis Rheum 1995;38:1457-65.
24. Cronstein BN, Naime D, Ostad E. The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. J Clin Invest 1993;92:2675-82.
25. Klein CL, Köhler H, Bittinger F et al. Comparative studies on vascular endothelium in vitro. I. Cytokine effects on the expression of adhesion molecules by human umbilical vein, saphenous vein and femoral artery endothelial cell. Pathobiology 1994;62:199-208.
26. Elliott MJ, Maini RN. Anti-cytokine therapy in rheumatoid arthritis. Baillière's Clin Rheumatol 1995;9:633-52.
27. Chu CQ, Field M, Feldmann M, Maini RN. Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
28. Wood NC, Dickens E, Symnons JA, Duff GW. In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. Clin Immunol Immunopathol 1991;62:295-300.
29. Young HA, Hardy KJ. Role of interferon-γ in immune cell regulation. J Leuk Biol 1995;58:373-81.
30. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 1990; 33:768-73.
31. Brennan FM, Maini RN, Feldmann M. TNFα - A pivotal role in rheumatoid arthritis? Br J Rheumatol 1992;31:293-8.
32. Arend WP, Dayer JM. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995;38: 151-60.
33. Smith-Oliver T, Noel LS, Stimpson SS, Yarmall DP, Connolly KM. Elevated levels of TNF in the joints of adjuvant arthritis rats. Cytokine 1993;5:298-304.
34. Tak PP, Smeets TJM, Daha MR et al. Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum 1997; 40:217-25.